Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback